Status:
RECRUITING
This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.
Lead Sponsor:
Shanghai Zhongshan Hospital
Collaborating Sponsors:
RenJi Hospital
First Affiliated Hospital of Zhejiang University
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
18-80 years
Brief Summary
This study is a prospective, multi-center, real world, observational study, which aims at evaluating the intermediate and long-term efficacy of endovascular treatment for TASC C\&D aortoiliac occlusiv...
Detailed Description
In the past decade, endovascular treatment has become the first-line treatment for iliac artery occlusion, while Aorta - bilateral femoral artery bypass surgery is preferred for more complex iliac art...
Eligibility Criteria
Inclusion
- Rutherford grades 3-6.
- Follow the follow-up arrangement.
- Age: 18-80 years old.
- The target lesions were in the lower abdominal aorta and/or the common iliac artery and/or the external iliac artery.
- The stenosis degree ≥50%, or restenosis (received PTA or other adjuvant therapy, including bare or covers stents), or complete occlusion, or the presence of aortailiac artery thrombosis after PMT or CDT thrombus clearance, and then further endovascular therapy perfomred.
- Signed informed consent.
Exclusion
- Known allergy to drugs used in this study, including antiplatelet or anticoagulant drugs, etc.
- Allergy to iodine contrast agent allergy;
- Coagulation dysfunction or hypercoagulability;
- Breast-feeding or pregnant women;
- Life expectancy \< 24 months;
- Body condition can not tolerate endovascular treatment;
- Type 2B, type 3 lower limb ischemia patients
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2032
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05391815
Start Date
April 1 2021
End Date
June 1 2032
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital, Fudan University
Shanghai, China